The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples